reference/17490969

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17490969

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
issn	1471-2407
issueIdentifier	1
pageRange	912-
publicationName	BMC Cancer
startingPage	912
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_beca9c92bbb97e57422f836c11a1637e
bibliographicCitation	Francies FZ, Wainstein T, De Leeneer K, Cairns A, Murdoch M, Nietz S, Cubasch H, Poppe B, Van Maerken T, Crombez B, Coene I, Kerr R, Slabbert JP, Vral A, Krause A, Baeyens A, Claes KB. BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer. BMC Cancer. 2015 Nov 17;15():912. PMID: 26577449; PMCID: PMC4647511.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_af6b8d4dbb3f96ba38011e53822ccd48 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5dc2929ea7aa9a97efcaea783e39254 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00221e8dee850bb3cd6bca9a95617060 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31ec2ad3f429a32dddffbe05cbe71251 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c22ca9b5f69060b28d479e8b492f5861 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc3aa8e79fe23772de65d33134f2c0d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae14d4780ce781b5d34691e70f3767bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3a2a023cbd8d1e04273cd32860dc695 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8417d90b1d8616be6f59ffbe0c62fa32 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77f6cd7c666b0237715fc8fbfe9a2dd8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_720737b46d6b7c9272136952e5b68e78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0f5f10e274310c9dfce8721261c5ffb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c68e00788a5bd66f7550778d1b80c809 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e33a44266b76c0780a1dc7121df20c08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab1637bb4038bf342edda2afffeca392 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54ec0a01633f0a204785dcacfb7493ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_047dffe60d93935d77dcefe31983d1ae
date	2015-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4647511 https://pubmed.ncbi.nlm.nih.gov/26577449 https://doi.org/10.1186/s12885-015-1913-6
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22020 https://portal.issn.org/resource/ISSN/1471-2407
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer
discusses	http://id.nlm.nih.gov/mesh/M000632389 http://id.nlm.nih.gov/mesh/M0501109 http://id.nlm.nih.gov/mesh/M0451044 http://id.nlm.nih.gov/mesh/M0549409 http://id.nlm.nih.gov/mesh/M0245645 http://id.nlm.nih.gov/mesh/M0028758 http://id.nlm.nih.gov/mesh/M0374857 http://id.nlm.nih.gov/mesh/M0242709 http://id.nlm.nih.gov/mesh/M0015042
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/11 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6f3ef4a5ab86c1588ba1fc89f4c730bb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_533622b82f51bc5431a771c088f3bdd9 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a423d85fa652b3ac7e8f59032ac788b2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7245816ddc6efc7bb53c482189bd33ab http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID79728 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID675 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11200 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID672

Total number of triples: 58.